CIPLABSECIPLA LTD· PharmaceuticalsMediumNeutral
Announced Tue, 27 Oct, 2026 · 13:48 IST

Rashmi Joshi appointed additional independent director for five years

CIPLA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.2%Reaction day
₹1347.10
prior close
₹1323.70
announcement price
In-mkt
timing
Nifty 100marketpendingvs market: pending
Pharmaceuticals peers, median of 173sector+2.0%-1.8% vs sector

On the reaction day the stock moved 1.8 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.2
10m
-0.0
15m
+0.2
30m
+0.6
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.2pendingpending+2.0-1.8
Next day
—————
2d
—————
3d
—————
4d
—————
5d
—————
1w
—————
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty 100Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Cipla's board approved Rashmi Joshi's appointment as an additional independent director effective 27 October 2026 for five years, through 26 October 2031. The appointment requires shareholder approval. Joshi is a Chartered Accountant and Company Secretary with over 30 years of experience in finance, risk management and corporate governance.

Likely market impact

Adds an experienced independent director with finance, risk and governance expertise, subject to shareholder approval.